Log in

REDHILL BIOPHAR/S SEC Filings & 10K Form (NASDAQ:RDHL)

$6.29
+0.02 (+0.32 %)
(As of 10/16/2019 04:08 AM ET)
Today's Range
$6.18
Now: $6.29
$6.53
50-Day Range
$5.76
MA: $7.32
$8.18
52-Week Range
$5.13
Now: $6.29
$9.57
Volume60,849 shs
Average Volume68,986 shs
Market Capitalization$137.98 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

SEC Filings

REDHILL BIOPHAR/S (NASDAQ:RDHL) SEC Filings

DateFilerForm TypeView
10/11/2019
8:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2019
5:30 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2019
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2019
11:15 PM
REDHILL BIOPHAR/S (Filer)
Form EFFECT
07/24/2019
6:03 AM
REDHILL BIOPHAR/S (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
07/24/2019
6:02 AM
REDHILL BIOPHAR/S (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/23/2019
7:31 AM
REDHILL BIOPHAR/S (Filer)
Form 424B5
07/23/2019
7:31 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2019
6:27 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2019
8:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2019
4:01 PM
Ibex Investors LLC (Filed by)
REDHILL BIOPHAR/S (Subject)
Form SC 13G
06/10/2019
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2019
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2019
6:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2019
8:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2019
8:03 AM
REDHILL BIOPHAR/S (Filer)
Form 20-F/A
05/09/2019
9:54 AM
REDHILL BIOPHAR/S (Filer)
Form CT ORDER
05/09/2019
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
5:06 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2019
7:28 AM
REDHILL BIOPHAR/S (Filer)
Form CT ORDER
03/04/2019
7:03 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2019
6:01 AM
REDHILL BIOPHAR/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2019
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2019
11:53 AM
First Investments Holding Ltd (Filed by)
REDHILL BIOPHAR/S (Subject)
Form SC 13G/A
02/19/2019
8:30 AM
First Investments Holding Ltd (Filed by)
REDHILL BIOPHAR/S (Subject)
Form SC 13G
02/19/2019
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
10:43 AM
683 Capital Management, LLC (Filed by)
REDHILL BIOPHAR/S (Subject)
Form SC 13G/A
01/17/2019
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2018
9:44 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2018
12:56 PM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2018
11:03 AM
REDHILL BIOPHAR/S (Filer)
Form 424B5
12/06/2018
7:53 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2018
3:03 PM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2018
6:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2018
2:00 PM
REDHILL BIOPHAR/S (Filer)
Form CT ORDER
11/14/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2018
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2018
8:26 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2018
6:08 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/24/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2018
9:17 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2018
11:30 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/10/2018
8:04 AM
REDHILL BIOPHAR/S (Filer)
Form 424B5
08/09/2018
8:10 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2018
5:58 AM
REDHILL BIOPHAR/S (Filer)
Form 424B5
08/06/2018
3:01 PM
683 Capital Management, LLC (Filed by)
REDHILL BIOPHAR/S (Subject)
Form SC 13G
08/01/2018
7:18 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2018
11:15 PM
REDHILL BIOPHAR/S (Filer)
Form EFFECT
07/30/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2018
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2018
7:23 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2018
7:02 AM
REDHILL BIOPHAR/S (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
07/23/2018
6:15 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2018
8:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2018
5:03 AM
REDHILL BIOPHAR/S (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2018
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2018
7:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2018
7:55 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2018
10:41 AM
REDHILL BIOPHAR/S (Filer)
Form CT ORDER
04/09/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2018
1:41 PM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2018
4:12 PM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2018
7:01 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2018
6:17 AM
REDHILL BIOPHAR/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/22/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2018
6:00 AM
REDHILL BIOPHAR/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Preferred Stock

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel